Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gadi Peleg currently holds 5,374 shares of Artemis Therapeutics, Inc. (ATMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gadi Peleg has been a net buyer of ATMS stock. They have purchased $1.0M and sold $47 worth of shares.
Gadi Peleg's most recent insider trade was on Dec 18, 2018, when they sold 182 shares at $0.26 per share.
Gadi Peleg serves as Executive at Artemis Therapeutics, Inc. (ATMS). They have executed 5 insider transactions totaling $1.0M over their tenure at the company.
Gadi Peleg holds the position of Executive at Artemis Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Gadi Peleg has shown a buying trading pattern, with $1.0M in total purchases and $47 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gadi Peleg was on Mar 11, 2010, when they purchased $416.0K worth of INKS.OB shares. This transaction involved 3,200,000 shares at $0.13 per share.
Gadi Peleg currently owns 5,374 shares of Artemis Therapeutics, Inc. (ATMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gadi Peleg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gadi Peleg has 5 Form 4 filings on record as an insider at Artemis Therapeutics, Inc..
Set alerts for Gadi Peleg and 40,000+ other insiders.